(2) transactions between or among the Issuer and/or its Restricted Subsidiaries;
(4) payment of reasonable and customary fees, indemnification and similar arrangements (including the payment of directors' and officers' insurance premiums) and reimbursements of expenses and legal fees (pursuant to indemnity arrangements or otherwise) of Officers, directors, employees or consultants of the Issuer or any of its Restricted Subsidiaries;
(5) any issuance of Equity Interests (other than Disqualified Stock) of the Issuer to Affiliates of the Issuer;
(6) any Investment (other than a Permitted Investment) or other Restricted Payment, in either case, that does not violate the provisions of the Indenture described above under the caption ``--Restricted Payments";
(7) any Permitted Investment described in clauses (4), (5), (6), (8), (10), (11) and (14) of the definition thereof;
(8) [Reserved];
133
(9) transactions pursuant to, or contemplated by any agreement in effect on the Issue Date and transactions pursuant to any amendment, modification or extension to such agreement, so long as such amendment, modification or extension, taken as a whole, is not-materially more disadvantageous to the holders of the Notes than the original agreement as in effect on the Issue Date;
(10) the entering into any agreement to pay and the payment of Management Advances and the payment of fees and expenses related to the offering as set forth under the caption "Use of Proceeds";
